Tilray Inc (NASDAQ:TLRY – Get Free Report) shares traded down 3.2% on Monday . The stock traded as low as $1.67 and last traded at $1.68. 9,461,924 shares were traded during trading, a decline of 68% from the average session volume of 29,250,340 shares. The stock had previously closed at $1.73.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on the stock. Alliance Global Partners raised their price target on shares of Tilray from $2.25 to $2.75 and gave the company a “neutral” rating in a research report on Friday, April 5th. CIBC reduced their price target on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating for the company in a research report on Wednesday, April 10th. Finally, Canaccord Genuity Group reduced their price target on shares of Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th.
View Our Latest Analysis on Tilray
Tilray Stock Up 7.0 %
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. Clear Street Markets LLC bought a new position in Tilray during the 3rd quarter valued at about $25,000. Lake Street Financial LLC bought a new position in Tilray during the 3rd quarter valued at about $28,000. Gainplan LLC bought a new position in Tilray during the 4th quarter valued at about $28,000. RPO LLC bought a new position in Tilray during the 4th quarter valued at about $28,000. Finally, Great Valley Advisor Group Inc. bought a new position in Tilray in the 3rd quarter worth about $29,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Recommended Stories
- Five stocks we like better than Tilray
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Technologies to Challenge NAND Flash Dominance in AI
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Is Zoom Video Stock Getting Too Cheap to Pass Up?
- The How And Why of Investing in Oil Stocks
- Packaging Corporation of America: Buy The Dip
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.